MedPath

贵州圣济堂制药有限公司

Ownership
-
Established
1996-02-16
Employees
-
Market Cap
-
Website
https://gzsjt000.chemdrug.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

87

NMPA:87

Drug Approvals

噙化上清片

Approval Number
国药准字Z52020414
Approval Date
Sep 25, 2024
NMPA

Metformin Hydrochloride Enteric-coated Tablets

Product Name
盐酸二甲双胍肠溶片
Approval Number
国药准字H20044070
Approval Date
Sep 25, 2024
NMPA

Gliclazide Tablets(Ⅱ)

Product Name
格列齐特片(Ⅱ)
Approval Number
国药准字H20003279
Approval Date
Sep 25, 2024
NMPA

Glimepiride Tablets

Product Name
圣平
Approval Number
国药准字H20010556
Approval Date
Sep 25, 2024
NMPA

Metformin Hydrochloride Enteric-coated Tablets

Product Name
盐酸二甲双胍肠溶片
Approval Number
国药准字H52020955
Approval Date
Sep 25, 2024
NMPA

桑姜感冒片

Approval Number
国药准字Z52020046
Approval Date
Sep 25, 2024
NMPA

感冒康胶囊

Approval Number
国药准字Z52020041
Approval Date
Sep 25, 2024
NMPA

Glipizide Tablets

Product Name
格列吡嗪片
Approval Number
国药准字H20003280
Approval Date
Sep 25, 2024
NMPA

灵芝胶囊

Approval Number
国药准字Z52020044
Approval Date
Sep 25, 2024
NMPA

Venlafaxine Hydrochloride Tablets

Product Name
盐酸文拉法辛片
Approval Number
国药准字H20140089
Approval Date
May 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.